Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I A Shchukin

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 20, 2025
[Neurocytoprotection advances in reperfusion therapy]I A Shchukin, I A Koltsov, M S Fidler, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 19, 2022
[COVID-19 related stroke]I A Shchukin, M S Fidler, I A Koltsov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 15, 2026
[Drug-drug interactions with Mexidol in patients with ischemic stroke: Analysis of data from randomized clinical trials]E V Shikh, N A Shamalov, S N Yanishevsky, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 14, 2023
[Efficacy and safety of the drug Cellex for the treatment of patients with cognitive impairment with chronic cerebral ischemia - results of a multicenter randomized double-blind placebo-controlled clinical trial]I A Shchukin, I A Koltsov, M S Fidler, et al.
Neuroscience and Behavioral Physiology|September 19, 2022
COVID-19-Associated StrokeI A Shchukin, M S Fidler, I A Koltsov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 13, 2021
[Treatment of multiple sclerosis with glatiramer acetate: a new look]A N Boyko, N F Smirnova, I A Shchukin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 13, 2021
[Ofatumumab - a new drug for the treatment of multiple sclerosis]A N Boyko, N F Smirnova, I A Shchukin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 28, 2025
[Multimodal antioxidant therapy in ischemic stroke: from MIR trial to bedside]I A Koltsov, I A Shchukin, M S Fidler, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 23, 2024
[Posterior reversible encephalopathy syndrome in autoimmune disorders]I A Koltsov, I A Shchukin, M S Fidler, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 21, 2024
[The relationship between the development of post-stroke cognitive impairment and changes in the coagulation component of hemostasis]I A Koltsov, I A Shchukin, E A Kovalenko, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 20, 2025
[Neurocytoprotection advances in reperfusion therapy]I A Shchukin, I A Koltsov, M S Fidler, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 19, 2022
[COVID-19 related stroke]I A Shchukin, M S Fidler, I A Koltsov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 15, 2026
[Drug-drug interactions with Mexidol in patients with ischemic stroke: Analysis of data from randomized clinical trials]E V Shikh, N A Shamalov, S N Yanishevsky, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 14, 2023
[Efficacy and safety of the drug Cellex for the treatment of patients with cognitive impairment with chronic cerebral ischemia - results of a multicenter randomized double-blind placebo-controlled clinical trial]I A Shchukin, I A Koltsov, M S Fidler, et al.
Neuroscience and Behavioral Physiology|September 19, 2022
COVID-19-Associated StrokeI A Shchukin, M S Fidler, I A Koltsov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 13, 2021
[Treatment of multiple sclerosis with glatiramer acetate: a new look]A N Boyko, N F Smirnova, I A Shchukin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 13, 2021
[Ofatumumab - a new drug for the treatment of multiple sclerosis]A N Boyko, N F Smirnova, I A Shchukin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 28, 2025
[Multimodal antioxidant therapy in ischemic stroke: from MIR trial to bedside]I A Koltsov, I A Shchukin, M S Fidler, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 23, 2024
[Posterior reversible encephalopathy syndrome in autoimmune disorders]I A Koltsov, I A Shchukin, M S Fidler, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 21, 2024
[The relationship between the development of post-stroke cognitive impairment and changes in the coagulation component of hemostasis]I A Koltsov, I A Shchukin, E A Kovalenko, et al.
Pageof 3